Commentary: Who's afraid of the RAC? Lessons from the oversight of controversial science.
This commentary asks what we can learn from our oversight of controversial science and how can we do better in the future? After briefly examining the history of gene transfer research oversight, some observations are offered for the oversight of nanobiotechnology and other emerging areas of science.
Kahn
Jeffrey P
JP
Center for Bioethics at University of Minnesota, USA.
D026683:Advisory Committees; D004274:DNA, Recombinant; D018014:Gene Transfer Techniques; D036281:Genetic Research / Q000331:legislation & jurisprudence; D015316:Genetic Therapy / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006801:Humans; D036103:Nanotechnology / Q000331:legislation & jurisprudence*; D009316:National Institutes of Health (U.S.); D011050:Policy Making; D014481:United States
D004274:DNA, Recombinant